Koru Pharma Expands Global Reach with Latest Launches at IMCAS ASIA 2024

Koru Pharma Co., Ltd. (CEO, Roman Vernidub) announced on July 11th that they participated in the ‘IMCAS ASIA 2024‘ held in Bangkok from June 21 to 23, 2024.

“IMCAS” (International Master Course on Aging Science) is one of the world’s three major global medical aesthetic events that share the latest research results and technologies in the fields of dermatology and plastic surgery. As interest in beauty and plastic surgery has risen in Asia, “IMCAS ASIA” has been held separately every year since 2007. Marking its 17th anniversary this year, IMCAS ASIA 2024 was attended by 110 companies related to beauty and plastic surgery, with more than 3,200 visitors, mainly dermatologists and plastic surgery experts.

At this fair, Koru Pharma received a lot of attention from participants by introducing its recently launched line-up of skin boosters such as Crystal Healer PN, Crystal Healer PN+, Mesoheal Amber Glow, and Mesoheal Orchid Glow. Crystal Healer PN is a new product with a high concentration of PN (Polynucleotide; at 2.5%), which is excellent for skin regeneration. The PN component extracted from the milt of a salmon is an ingredient that is currently in the spotlight because it helps regenerate skin and strengthen elasticity in the body.

“This exhibition gave us a great opportunity to strengthen our position in the Asian market and expand our global network,” a Koru Pharma official said. “Thanks to the enthusiastic response of buyers, we are looking forward to increasing sales and expanding the market in the future.” “We will continue to do our best to further solidify our position in the global market through innovative product development and active marketing activities, and to provide better skin care solutions to customers around the world,” the official said. 

In addition to IMCAS ASIA 2024 this year, Koru Pharma is participating in leading international exhibitions such as “IMCAS World Congress,” “DUBAI DERMA,” “CIBE Guanzhou,” “AMWC Monaco,” “IMCAS Americas,” and “CBE Shanghai,” and will continue to expand its customer contact points by participating in four international exhibitions in the second half of the year. In addition, it is focusing on strengthening the customer experience by directly promoting the safety and reliability of the product to customers through its own aesthetic seminar called the Aesthetic Training Program (ATP).

Koru Pharma Co., Ltd., founded in 2016, is a leading company in the K-beauty industry, specialising in cosmetic and medical products. The company’s main products include filler injections and skin boosters, tailored to market demand. These products are distributed globally, reaching approximately 120 countries, including 41 in Europe. Koru Pharma aims to become the top Health Care & Beauty company by showcasing the strength of K-beauty through the commercialisation of next-generation fillers that do not use crosslinking agents。

Source from newspim.com